-
The "bivalent" vaccine — meaning it targets two different antigens — is Moderna's leading candidate to have an effective booster ready for fall of 2022, the company said.
-
Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.
-
After the state threatened to impose a $27.5 million fine, Gov. Ron DeSantis said Friday that the Special Olympics USA Games will not have a COVID-19 vaccination requirement this week in Orlando.
-
COVID-19 vaccinations for children younger than 5 could start right after the Juneteenth holiday.
-
Pfizer plans to submit new data to the Food and Drug Administration this week, bringing families with young children one step closer to a long-awaited vaccine.
-
The Centers for Disease Control and Prevention's advice opens a third COVID-19 shot to healthy elementary-age kids — just like what is already recommended for everybody 12 and older.
-
The Food and Drug Administration expanded authorization of Pfizer-BioNTech's COVID vaccine to enable kids ages 5 to 11 who were vaccinated at least five months ago to get a third shot.
-
A large share of the nearly 1 million people who died of COVID in the U.S. may have lived if they'd gotten vaccinated. A new analysis shows how many lives could have been saved across the country.
-
Politics, religion, distrust and disinformation all play a role. "I've realized that there's no convincing somebody once they have their mind made up," says a social worker in Beaumont, Texas.
-
USF Health professor Jill Roberts provides some possible explanations for this drop, including vaccine hesitancy that the COVID-19 pandemic intensified.
-
The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
-
In the third year of the coronavirus pandemic, knowing where to turn to get tested or vaccinated is still important. Here’s our updated guide: